VEGFA and liver dysplastic nodule: Treatment with P78-PEDF protected diabetic mice from DN displaying reduced albuminuria, kidney macrophage recruitment, histological changes, inflammatory cytokines, and fibrotic markers (kidney TNF-α, fibronectin, VEGFA, and EGFR), and restoration of nephrin expression [81].